Compare CMPX & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPX | SPCE |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 408.8M | 331.6M |
| IPO Year | 2020 | 2017 |
| Metric | CMPX | SPCE |
|---|---|---|
| Price | $2.00 | $2.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $14.57 | $3.06 |
| AVG Volume (30 Days) | 2.5M | ★ 6.6M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,544,000.00 |
| Revenue This Year | N/A | $2,270.73 |
| Revenue Next Year | $934.41 | $880.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.61 | $2.13 |
| 52 Week High | $6.88 | $8.90 |
| Indicator | CMPX | SPCE |
|---|---|---|
| Relative Strength Index (RSI) | 38.72 | 47.24 |
| Support Level | $1.88 | $2.84 |
| Resistance Level | $2.08 | $3.39 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 1.96 | 20.90 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.